Results for antikoagulacijske translation from Croatian to English

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Croatian

English

Info

Croatian

antikoagulacijske lijekove (lijekove koji prorjeđuju krv)

English

anticoagulant medicines (which thin the blood)

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

mogu postojati situacije koje zahtijevaju promjenu antikoagulacijske terapije (tablica 2).

English

there may be situations that warrant a change in anticoagulation therapy (table 2).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

rizik od krvarenja može biti povećan uz istodobnu primjenu antitrombotske ili antikoagulacijske terapije.

English

the risk of haemorrhage may be increased with concomitant use of antiplatelet or anticoagulant therapy.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

zbog povećanog rizika od tromboze u bolesnika koji boluju od raka, česta je primjena antikoagulacijske terapije.

English

due to the increased thrombotic risk in patients with cancer, the use of anticoagulation is frequent.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

leukaferezu ne bi trebalo provoditi u darivatelja koji uzimaju antikoagulacijske lijekove ili za koje se zna da imaju narušenu hemostazu.

English

leukapheresis should not be performed in donors who are anticoagulated or who have known defects in haemostasis.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

inr nije odgovarajuća mjera antikoagulacijske aktivnosti lijeka xarelto i stoga se ne smije koristiti (vidjeti dio 4.5).

English

the inr is not valid to measure the anticoagulant activity of xarelto, and therefore should not be used (see section 4.5).

Last Update: 2017-04-26
Usage Frequency: 2
Quality:

Croatian

odmah nakon primjene idarucizumaba, koncentracije nevezanog dabigatrana u plazmi smanjile su se za više od 99%, što je rezultiralo razinama bez antikoagulacijske aktivnosti.

English

immediately after the administration of idarucizumab, the plasma concentrations of unbound dabigatran were reduced by more than 99 %, resulting in levels with no anticoagulant activity.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

ako uzimate druge lijekove za sprječavanje zgrušavanja krvi (npr. varfarin, dabigatran, rivaroksaban, apiksaban ili heparin), osim kod promjene antikoagulacijske terapije ili kod primanja heparina kroz vensku ili arterijsku liniju da bi ostala prohodna

English

if you are taking other medicines to prevent blood clotting (e.g. warfarin, dabigatran, rivaroxaban, apixaban or heparin), except when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

bolesnici koji primaju oralne antikoagulanse: primjena metalysea se može razmotriti ako se zbog doziranja ili vremena od posljednjeg unosa antikoagulacijskog liječenja rezidualna djelotvornost smatra malo vjerojatno, te ukoliko odgovarajući test(-ovi) antikoagulacijske aktivnosti određenog(/-ih) lijeka(/-ova) ne pokazuje(/-u) klinički značajnu aktivnost na sustav koagulacije (npr.

English

patients receiving oral anticoagulants: the use of metalyse may be considered when dosing or time since the last intake of anticoagulant treatment makes residual efficacy unlikely and if appropriate test(s) of anticoagulant activity for the product(s) concerned show no clinically relevant activity on the coagulation system (e.g.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

bolesnici koji primaju oralne antikoagulanse: primjena metalysea se može razmotriti ako se zbog doziranja ili vremena od posljednjeg unosa antikoagulacijskog liječenja, rezidualna djelotvornost smatra malo vjerojatnom, te ukoliko odgovarajući test(-ovi) antikoagulacijske aktivnosti određenog(/-ih) lijeka(/-ova) ne pokazuje(/-u) klinički značajnu aktivnost na sustav koagulacije (npr.

English

patients receiving oral anticoagulants: the use of metalyse may be considered when dosing or time since the last intake of anticoagulant treatment makes residual efficacy unlikely and if appropriate test(s) of anticoagulant activity for the product(s) concerned show no clinically relevant activity on the coagulation system (e.g.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

istovremeno liječenje drugim antikoagulansom, npr. nefrakcionirani heparini (ufh), niskomolekularni heparini (enoksaparin, dalteparin, itd.), derivati heparina (fondaparinuks, itd.), oralnim antikoagulansima (varfarin, rivaroksaban, apiksaban, itd.) osim u specifičnim okolnostima prijelaza antikoagulacijske terapije (vidjeti dio 4.2) ili kada se ufh daje pri dozama potrebnima za održavanje prohodnosti središnjeg venskog ili arterijskog katetera (vidjeti dio 4.5)

English

concomitant treatment with any other anticoagulants e.g. unfractionated heparin (ufh), low molecular weight heparins (enoxaparin, dalteparin etc), heparin derivatives (fondaparinux etc), oral anticoagulants (warfarin, rivaroxaban, apixaban etc) except under specific circumstances of switching anticoagulant therapy (see section 4.2) or when ufh is given at doses necessary to maintain an open central venous or arterial catheter (see section 4.5)

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

istovremeno liječenje drugim antikoagulansom, npr. nefrakcioniranim heparinom (ufh), niskomolekularnim heparinom (enoksaparin, dalteparin, itd), derivatima heparina (fondaparinuks, itd.), oralnim antikoagulansima (varfarin, rivaroksaban, apiksaban, itd.) osim u specifičnim okolnostima prijelaza antikoagulacijske terapije (vidjeti dio 4.2), ili kada se ufh daje pri dozama potrebnima za održavanje prohodnosti središnjeg venskog ili arterijskog katetera (vidjeti dio 4.5)

English

concomitant treatment with any other anticoagulants e.g. unfractionated heparin (ufh), low molecular weight heparins (enoxaparin, dalteparin etc), heparin derivatives (fondaparinux etc), oral anticoagulants (warfarin, rivaroxaban, apixaban etc) except under specific circumstances of switching anticoagulant therapy (see section 4.2) or when ufh is given at doses necessary to maintain an open central venous or arterial catheter (see section 4.5)

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

općenito, može se smatrati da ove mjere antikoagulacijske aktivnosti mogu odražavati vrijednosti dabigatrana te mogu upućivati na ocjenu rizika od krvarenja, tj. kada prelaze 90. percentilu najnižih vrijednosti dabigatrana, ili se test koagulacije, kao što je aptv, mjeren pri najnižih koncentracijama (za aptv prag vidjeti tablicu 2 u dijelu 4.4), smatra povezanim s povećanim rizikom od krvarenja.

English

in general, it can be assumed that these measures of anti-coagulant activity may reflect dabigatran levels and can provide guidance for the assessment of bleeding risk, i.e. exceeding the 90th percentile of dabigatran trough levels or a coagulation assay such as aptt measured at trough (for aptt thresholds see section 4.4, table 2) is considered to be associated with an increased risk of bleeding.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Croatian

općenito, može se smatrati da ove mjere antikoagulacijske aktivnosti mogu odražavati vrijednosti dabigatrana te mogu upućivati na ocjenu rizika od krvarenja, tj. kada prelaze 90. percentilu najnižih vrijednosti dabigatrana, ili se test koagulacije, kao što je aptv, mjeren pri najnižim koncentracijama (za aptv prag vidjeti tablicu 2 u dijelu 4.4), smatra povezanim s povećanim rizikom od krvarenja.

English

in general, it can be assumed that these measures of anti-coagulant activity may reflect dabigatran levels and can provide guidance for the assessment of bleeding risk, i.e. exceeding the 90th percentile of dabigatran trough levels or a coagulation assay such as aptt measured at trough (for aptt thresholds see section 4.4, table 2) is considered to be associated with an increased risk of bleeding.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Get a better translation with
4,401,923,520 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK